APP and Alzheimer disease: Experimental validation of the hypothesis came from transgenic mouse models expressing mutant forms of human APP, such as transgenic mice expressing mutant human APP (PDAPP V717F [APP751 isoform]), which developed Aβ plaques consistent with those observed in human AD brains [33,34].